William Ekecrantz is a Senior Bioprocess Engineer at BioLamina, currently engaged in upstream process development. They previously worked as a Bioprocess Engineer at XNK Therapeutics and served as a Quality Assurance Officer at AstraZeneca. Ekecrantz completed a Master's thesis at the University of Copenhagen, investigating glucose metabolism in primary T cells, and has held research positions at Procella Therapeutics AB and Lund University. They earned a Bachelor of Science in Biomedical Sciences from Lund University and a Master of Science in Immunology and Inflammation from the University of Copenhagen.
Location
Stockholm, Sweden
This person is not in any offices